Literature DB >> 8078636

Shape preserving three-dimensional display of myocardial scintigraphic data.

A Loboguerrero1, C Pérault, C Gibold, J Ouzan, T Pron, A Bouchard, A Lepailleur, J C Liehn.   

Abstract

A three-dimensional display has been developed which is specifically suited to the visualization of myocardial single photon emission tomographic (SPET) data. A set of radial maxima voxels, representative of the whole left ventricle uptake and shape is first extracted by cylindrical and spherical sampling of the short axis slices. A three-dimensional representation of these voxels is then obtained, with hues depicting the uptake amount and shades (i.e. intensity and saturation) depicting the shape. This technique is suitable for 201Tl and 99TCm-hexakis-2-methoxyisobutyl isonitrile (99TCm-sestamibi) myocardial images. It is proposed as an aid to interpreting myocardial SPET as it enables the physician to distinguish simultaneously the actual shape, the extent and the severity of perfusion defects on a single frame.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078636     DOI: 10.1097/00006231-199406000-00004

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  3 in total

1.  Three-dimensional visualisation of the large bowel: a potential tool for assessing targeted drug delivery and colonic pathology.

Authors:  A C Perkins; C Mann; C G Wilson
Journal:  Eur J Nucl Med       Date:  1995-09

2.  Surface rendering of three-dimensional myocardial SPECT: clinical usefulness compared with bull's-eye and conventional tomograms.

Authors:  J L Demangeat; P Gries; A Bessekri; F Fellinger
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

3.  Clinical application of three-dimensional myocardial imaging: evaluation of efficacy of medical treatment on myocardial perfusion.

Authors:  J Yamazaki; H Hosoi; S Ishiguro; H Muto; H Yamashina; T Morishita; M Takano; J Sugita; M Takahashi
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.